Mesenchymal stromal cells: new directions.

[1]  K. Johnson.  A stem cell-based approach to cartilage repair , 2013 .

[2]  P. Giannoudis,et al.  Transcriptional profile of native CD271+ multipotential stromal cells: evidence for multiple fates, with prominent osteogenic and Wnt pathway signaling activity. , 2012, Arthritis and rheumatism.

[3]  D. Prockop,et al.  Relearning the Lessons of Genomic Stability of Human Cells During Expansion in Culture: Implications for Clinical Research , 2012, Stem cells.

[4]  Peter G. Schultz,et al.  A Stem Cell–Based Approach to Cartilage Repair , 2012, Science.

[5]  S. Messinger,et al.  Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. , 2012, JAMA.

[6]  Jeffrey M Karp,et al.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. , 2012, Cell stem cell.

[7]  Charles P. Lin,et al.  Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. , 2012, Cell stem cell.

[8]  A. Bartholomew,et al.  Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. , 2012, Blood.

[9]  K. Tarte,et al.  Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. , 2012, Cell stem cell.

[10]  J. Davies,et al.  Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction , 2011, Basic Research in Cardiology.

[11]  Yoav Mayshar,et al.  Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. , 2011, Cell stem cell.

[12]  M. Yen,et al.  Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells , 2011, Journal of Biomedical Science.

[13]  D. Prockop,et al.  Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. , 2011, Blood.

[14]  S. Lim,et al.  Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. , 2011, Regenerative medicine.

[15]  M. Kolonin,et al.  An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells. , 2011, Cell stem cell.

[16]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[17]  M. Ehinger,et al.  CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. , 2011, Blood.

[18]  N. Fujii,et al.  The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. , 2010, Immunity.

[19]  Ben D. MacArthur,et al.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.

[20]  Jakub Tolar,et al.  Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells , 2010, Stem cells.

[21]  S. Kadam,et al.  Human breast milk is a rich source of multipotent mesenchymal stem cells , 2010, Human Cell.

[22]  Ruth S. Waterman,et al.  A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype , 2010, PloS one.

[23]  J. Kramer,et al.  Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology? , 2010, Transfusion Medicine and Hemotherapy.

[24]  Joshua M Hare,et al.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[25]  J. Davies,et al.  Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic Hierarchy , 2009, PloS one.

[26]  P. Delafontaine,et al.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.

[27]  Min-jung Park,et al.  Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10 , 2009, Experimental & Molecular Medicine.

[28]  Yufang Shi,et al.  Species Variation in the Mechanisms of Mesenchymal Stem Cell‐Mediated Immunosuppression , 2009, Stem cells.

[29]  A. Keating,et al.  Bone Marrow‐Derived Mesenchymal Stromal Cells Express Cardiac‐Specific Markers, Retain the Stromal Phenotype, and Do Not Become Functional Cardiomyocytes In Vitro , 2008, Stem cells.

[30]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[31]  G. Dini,et al.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.

[32]  P. Bianco,et al.  Mesenchymal stem cells: revisiting history, concepts, and assays. , 2008, Cell stem cell.

[33]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell stem cell.

[34]  Ruth S. Waterman,et al.  Toll‐Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses , 2008, Stem cells.

[35]  L. Cosmi,et al.  Toll‐Like Receptors 3 and 4 Are Expressed by Human Bone Marrow‐Derived Mesenchymal Stem Cells and Can Inhibit Their T‐Cell Modulatory Activity by Impairing Notch Signaling , 2008, Stem cells.

[36]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[37]  O. Ringdén,et al.  Immunomodulation by mesenchymal stem cells and clinical experience , 2007, Journal of internal medicine.

[38]  B. Sacchetti,et al.  Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment , 2007, Cell.

[39]  A. Cope,et al.  The Antiproliferative Effect of Mesenchymal Stem Cells Is a Fundamental Property Shared by All Stromal Cells1 , 2007, The Journal of Immunology.

[40]  T. Nagasawa,et al.  Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. , 2006, Immunity.

[41]  Meir Liebergall,et al.  Osteogenic Differentiation of Noncultured Immunoisolated Bone Marrow‐Derived CD105+ Cells , 2006, Stem cells.

[42]  Kotaro Yoshimura,et al.  Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates , 2006, Journal of cellular physiology.

[43]  W. Chiu,et al.  Isolation and Characterization of Neurogenic Mesenchymal Stem Cells in Human Scalp Tissue , 2005, Stem cells.

[44]  Dolores Baksh,et al.  Human Umbilical Cord Perivascular (HUCPV) Cells: A Source of Mesenchymal Progenitors , 2005, Stem cells.

[45]  F. Claas,et al.  Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta , 2004, Stem cells.

[46]  Chun-Chieh Huang,et al.  Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical Cord , 2004, Stem cells.

[47]  I. Weissman,et al.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.

[48]  David A. Williams,et al.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.

[49]  F. Djouad,et al.  Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. , 2003, Blood.

[50]  Paul Emery,et al.  Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. , 2002, Arthritis and rheumatism.

[51]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[52]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[53]  F. Luyten,et al.  Multipotent mesenchymal stem cells from adult human synovial membrane. , 2001, Arthritis and rheumatism.

[54]  S. Gronthos,et al.  Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R Cancedda,et al.  Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. , 2000, Journal of cell science.

[56]  P. Conget,et al.  Mesenchymal progenitor cells in human umbilical cord blood , 2000, British journal of haematology.

[57]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[58]  A. Keating,et al.  Biology of Bone Marrow Stroma , 1995, Annals of the New York Academy of Sciences.

[59]  J. Singer,et al.  Proteoglycans in human long-term bone marrow cultures: biochemical and ultrastructural analyses. , 1986, Blood.

[60]  H. Broxmeyer,et al.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. , 1980, Blood.

[61]  L. Lajtha,et al.  Conditions controlling the proliferation of haemopoietic stem cells in vitro , 1977, Journal of cellular physiology.

[62]  N. Kulagina,et al.  Fibroblast precursors in normal and irradiated mouse hematopoietic organs. , 1976, Experimental hematology.

[63]  A. Friedenstein,et al.  THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.

[64]  A. Friedenstein,et al.  Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. , 1968, Transplantation.

[65]  M. Yoder,et al.  Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells. , 2010, Experimental hematology.

[66]  Krisztián Németh,et al.  Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.

[67]  E. Horwitz,et al.  How do mesenchymal stromal cells exert their therapeutic benefit? , 2008, Cytotherapy.

[68]  M. Soleimani,et al.  Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid. , 2007, Cytotherapy.

[69]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[70]  F. Marini,et al.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. , 2005, Cytotherapy.